ES2051682T3 - A PROCEDURE FOR THE PREPARATION OF A MAINTENANCE RELEASE COMPOSITION. - Google Patents

A PROCEDURE FOR THE PREPARATION OF A MAINTENANCE RELEASE COMPOSITION.

Info

Publication number
ES2051682T3
ES2051682T3 ES86114067T ES86114067T ES2051682T3 ES 2051682 T3 ES2051682 T3 ES 2051682T3 ES 86114067 T ES86114067 T ES 86114067T ES 86114067 T ES86114067 T ES 86114067T ES 2051682 T3 ES2051682 T3 ES 2051682T3
Authority
ES
Spain
Prior art keywords
release composition
procedure
preparation
maintenance release
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES86114067T
Other languages
Spanish (es)
Inventor
Keiji Fujioka
Shigeji Sato
Nobuhiko Tamura
Yoshihiro Takada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharmaceuticals Co Ltd
Original Assignee
Sumitomo Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP61223251A external-priority patent/JPH0761959B2/en
Application filed by Sumitomo Pharmaceuticals Co Ltd filed Critical Sumitomo Pharmaceuticals Co Ltd
Application granted granted Critical
Publication of ES2051682T3 publication Critical patent/ES2051682T3/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/2036—Silicones; Polysiloxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A sustained release composition applicable for human beings and mammals which comprises (a) a silicone elastomer and (b) a pharmaceutical substance optionally with (c) albumin. When the pharmaceutical substance is of high molecular weight and can exert its pharmaceutical effect in a trace amount, its continuous release over a long period is attained by application of this invention.
ES86114067T 1985-10-11 1986-10-10 A PROCEDURE FOR THE PREPARATION OF A MAINTENANCE RELEASE COMPOSITION. Expired - Lifetime ES2051682T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP22759085 1985-10-11
JP61223251A JPH0761959B2 (en) 1985-10-11 1986-09-19 Silicone elastomer-based sustained release formulation
JP61223250A JPS62174031A (en) 1985-10-11 1986-09-19 Sustained release pharmaceutical containing high-molecular weight drug

Publications (1)

Publication Number Publication Date
ES2051682T3 true ES2051682T3 (en) 1994-07-01

Family

ID=27330754

Family Applications (1)

Application Number Title Priority Date Filing Date
ES86114067T Expired - Lifetime ES2051682T3 (en) 1985-10-11 1986-10-10 A PROCEDURE FOR THE PREPARATION OF A MAINTENANCE RELEASE COMPOSITION.

Country Status (7)

Country Link
US (1) US4985253A (en)
EP (1) EP0219076B1 (en)
AT (1) ATE73321T1 (en)
AU (1) AU594088B2 (en)
DE (1) DE3684220D1 (en)
ES (1) ES2051682T3 (en)
NZ (1) NZ217844A (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU586306B2 (en) * 1985-12-16 1989-07-06 Ethicon Inc. Method for inhibiting post-surgical adhesion formation by the topical administration of tissue plasminogen activator
US4889722A (en) * 1985-12-16 1989-12-26 Ethicon, Inc. Method for inhibiting post-surgical adhesion formation by the topical administration of tissue plasminogen activator
US4761289A (en) * 1986-10-10 1988-08-02 International Minerals & Chemical Corp. Sustained release implant and method for preparing same
US5028430A (en) * 1987-05-08 1991-07-02 Syntex (U.S.A.) Inc. Delivery systems for the controlled administration of LHRH analogs
IL86933A (en) * 1987-07-01 1993-07-08 Genentech Inc Method and therapeutic compositions for the prevention of fibrin deposition for adhesions
JPH01186823A (en) * 1988-01-21 1989-07-26 Dow Corning Kk Production of medicament-permeating substance
FR2650502B1 (en) * 1989-08-07 1994-05-27 Delagrange Laboratoires NEW ORAL GALENIC FORM IMPROVING BIOAVAILABILITY
FR2653338B1 (en) * 1989-10-23 1994-06-10 Dow Corning Sa FORMULATION FOR SUSTAINED RELEASE DRUGS AND THE USE THEREOF.
US5650398A (en) * 1992-07-02 1997-07-22 Cambridge Biotech Corporation Drug delivery enhancement via modified saponins
US5273965A (en) * 1992-07-02 1993-12-28 Cambridge Biotech Corporation Methods for enhancing drug delivery with modified saponins
IL110787A0 (en) * 1993-08-27 1994-11-11 Sandoz Ag Biodegradable polymer, its preparation and pharmaceutical composition containing it
JP3720386B2 (en) * 1993-12-27 2005-11-24 住友製薬株式会社 Drug release controlled formulation
AU706351B2 (en) * 1994-03-18 1999-06-17 Alfred Schmidt The use of dimeticone as a transport and carrier system and/or drug delivery system
DE4409357C2 (en) * 1994-03-18 1996-10-17 Upmeyer Hans Juergen Use of Dimeticon to eradicate Heliobacter pylori
US6028062A (en) * 1995-03-15 2000-02-22 Upmeyer; Hans-Juergen Use of dimeticone for the local antibacterial therapy and/or the prevention and therapy of helicobacter pylori (Hp) associated syndromes and infectious diseases
PT858343E (en) 1995-11-02 2004-07-30 Schering Corp THERAPY FOR CONTINUOUS INFUSE OF A LOW DOSE OF CYTOKINE
US5908621A (en) 1995-11-02 1999-06-01 Schering Corporation Polyethylene glycol modified interferon therapy
TW586934B (en) * 1997-05-19 2004-05-11 Sumitomo Pharma Immunopotentiating composition
TW586944B (en) 1998-05-29 2004-05-11 Sumitomo Pharma Controlled release agent having a multi-layer structure
JP4753471B2 (en) * 1998-09-10 2011-08-24 大日本住友製薬株式会社 Long-term drug sustained-release preparation
US6056976A (en) * 1998-11-12 2000-05-02 Leiras Oy Elastomer, its preparation and use
TW524696B (en) * 1999-11-10 2003-03-21 Sumitomo Pharma Sustained-release drug formulations
AU2001249214A1 (en) 2000-03-15 2001-09-24 The Brigham And Women's Hospital, Inc. Suppression of vascular disorders by mucosal administration of heat shock protein peptides
WO2001093826A1 (en) * 2000-06-06 2001-12-13 Sumitomo Pharmaceuticals Company, Limited Biocompatible synthetic polymer preparations
NZ529347A (en) 2001-04-04 2008-01-31 Nordic Vaccine Technology As Use of at least one sterol capable of interacting with a nucleic acid and at least saponin to form immunostimulating complexes ( IMSCO )
DE602004008912T3 (en) 2004-07-13 2012-09-13 Bayer Schering Pharma Oy Retarded release system with controlled initial delivery
US7857856B2 (en) * 2005-03-15 2010-12-28 Warsaw Ortho Pedic, Inc. Composite spinal nucleus implant with water absorption and swelling capabilities
EP1874334A4 (en) * 2005-04-15 2011-03-30 Vascular Biogenics Ltd Compositions containing beta 2-glycoprotein i-derived peptides for the prevention and/or treatment of vascular disease
US8419793B2 (en) * 2008-09-19 2013-04-16 Mentor Worldwide Llc Coating with antimicrobial agents
US8420153B2 (en) * 2008-09-19 2013-04-16 Mentor Worldwide Llc Coating with antimicrobial agents
US9040062B2 (en) 2010-08-06 2015-05-26 Sumitomo Dainippon Pharma Co., Ltd. Preparation for treatment of spinal cord injury
US11338119B2 (en) * 2020-03-20 2022-05-24 The Regents Of The University Of California Implantable drug delivery devices for localized drug delivery
US11173291B2 (en) * 2020-03-20 2021-11-16 The Regents Of The University Of California Implantable drug delivery devices for localized drug delivery
US11344526B2 (en) 2020-03-20 2022-05-31 The Regents Of The University Of California Implantable drug delivery devices for localized drug delivery

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3279996A (en) * 1962-08-28 1966-10-18 Jr David M Long Polysiloxane carrier for controlled release of drugs and other agents
US3545439A (en) * 1968-01-04 1970-12-08 Upjohn Co Medicated devices and methods
US4464468A (en) * 1968-03-29 1984-08-07 Agence Nationale De Valorisation De La Recherche (Anvar) Immobilization of active protein by cross-linking to inactive protein
US4004979A (en) * 1968-03-29 1977-01-25 Agence Nationale De Valorisation De La Recherche (Anvar) Preparation of active proteins cross-linked to inactive proteins
BE791632A (en) * 1971-11-20 1973-05-21 Schering Ag SILICONIC RUBBER-BASED SUPPORTS FOR MEDICINAL PRODUCTS
DE2445971A1 (en) * 1974-09-24 1976-04-08 Schering Ag MEDICINAL INGREDIENTS CARRIERS II
US4053580A (en) * 1975-01-01 1977-10-11 G. D. Searle & Co. Microsealed pharmaceutical delivery device
US4164560A (en) * 1977-01-05 1979-08-14 Folkman Moses J Systems for the controlled release of macromolecules
US4391797A (en) * 1977-01-05 1983-07-05 The Children's Hospital Medical Center Systems for the controlled release of macromolecules
JPS5470384A (en) * 1977-08-22 1979-06-06 Inst Obu Kiyansaa Risaachi Roi High molecular complex
JPS54147916A (en) * 1978-05-12 1979-11-19 Sumitomo Chem Co Ltd Preparation of urokinase injection
US4191741A (en) * 1978-09-22 1980-03-04 Eli Lilly And Company Removable drug implant
US4376765A (en) * 1980-03-31 1983-03-15 Institut International De Pathologie Cellulaire Et Moleculaire Medicaments, their preparation and compositions containing same
US4357312A (en) * 1981-07-16 1982-11-02 The Children's Hospital Medical Center Method of making prolonged release body
US4478596A (en) * 1982-11-26 1984-10-23 Michelson Paul E Delivery system for physiologically active agents
US4613330A (en) * 1982-11-26 1986-09-23 Michelson Paul E Delivery system for desired agents
US4452775A (en) * 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
EP0139286B1 (en) * 1983-10-14 1991-08-21 Sumitomo Pharmaceuticals Company, Limited Prolonged sustained-release preparations
GB8400653D0 (en) * 1984-01-11 1984-02-15 Beecham Group Plc Conjugates
US4591496A (en) * 1984-01-16 1986-05-27 Massachusetts Institute Of Technology Process for making systems for the controlled release of macromolecules
US4559054A (en) * 1984-08-09 1985-12-17 Research Corporation Rate-controlled drug release system
US4650772A (en) * 1984-08-09 1987-03-17 Abbott Laboratories Monoclonal antibody stabilization
EP0224981A3 (en) * 1985-11-04 1988-08-10 Paco Research Corporation Nitroglycerin transdermal delivery system

Also Published As

Publication number Publication date
US4985253A (en) 1991-01-15
ATE73321T1 (en) 1992-03-15
AU6385486A (en) 1987-04-16
DE3684220D1 (en) 1992-04-16
AU594088B2 (en) 1990-03-01
EP0219076A3 (en) 1988-04-20
EP0219076A2 (en) 1987-04-22
NZ217844A (en) 1989-10-27
EP0219076B1 (en) 1992-03-11

Similar Documents

Publication Publication Date Title
ES2051682T3 (en) A PROCEDURE FOR THE PREPARATION OF A MAINTENANCE RELEASE COMPOSITION.
IT8720650A0 (en) DERIVATIVES OF THE IMMIDAZOQUINOLINYLIC ETHER WITH PHARMACEUTICAL ACTION AND PROCEDURE FOR THEIR PREPARATION.
ES553266A0 (en) PROCEDURE FOR THE PREPARATION OF DIPEPTIDES OF N, N'-DIALQUILGUANIDINO
MX9204268A (en) A COMPOSITION FOR THE PROLONGED AND CONTROLLED RELEASE OF MEDICINAL SUBSTANCES AND A PROCESS TO PREPARE THE SAME.
IT1231434B (en) INTRAVENOUS PHARMACEUTICAL COMPOSITION AND PROCEDURE FOR ITS PREPARATION.
ES2036737T3 (en) PROCEDURE FOR OBTAINING PHARMACEUTICAL MIXTURES.
MX9200180A (en) DERIVATIVES OF 5H-PIRROL (3,4-b) PIRAZINE OPTICALLY ACTIVE, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM.
DK203787D0 (en) NASAL ADMINISTRATION PREPARATION
IT1246341B (en) PERFECTED ADHESIVE COMPOSITION FOR DENTAL PROSTHESES AND PROCEDURE FOR ITS PREPARATION.
DE3679908D1 (en) HEXADECYLPHOSPHOCOLIN CONTAINING MEDICINAL PRODUCTS WITH ANTITUARY EFFECT.
IT1179635B (en) COMPOSITION AND PREPARATION FOR THE ADMINISTRATION OF MEDICATIONS BY SKIN
ES2017922B3 (en) 3-AMINO-4,5-DIHIDROXIPIPERIDINAS, PROCEDURE FOR ITS PREPARATION, AND ITS USE.
ES2014429B3 (en) NEW 4-TRIAZOL-4,3-A 1,4-BENZODIAZEPINES, PROCEDURE FOR ITS PREPARATION, ITS APPLICATION AS DRUGS AND CONTAINING PREPARATIONS.
MX9201058A (en) CYCLICAL DERIVATIVES OF CETAL, PROCEDURE FOR SUPREPARATION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM.
ES551635A0 (en) PROCEDURE FOR THE OBTAINING OF A PHARMACEUTICAL COMPOSITION OF DELAYED RELEASE BASED ON 9,10-DIHYDRO-ALCALOIDS.
IT1232819B (en) USE OF NUCLEOBASE SOURCES TO STIMULATE THE IMMUNE FUNCTION, RELATIVE PROCEDURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH SOURCE OF NUCLEOBASE
BR8204572A (en) CREAM BASE
MX6962E (en) PROCEDURE FOR THE PREPARATION OF AN ANTIDIARRHEAL PHARMACEUTICAL COMPOSITION
DE3675995D1 (en) MEDIUM WITH CONTINUOUS RELEASE OF PHENYLETHANOLAMINE DERIVATIVES.
IT8720271A0 (en) NEW DERIVATIVES OF ERGOLENE, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND PROCEDURE FOR THE PREPARATION OF THEM.
ES551634A0 (en) PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION BASED ON 3-AMINOPROPOXIINDOLES
ES2051916T3 (en) PROCEDURE FOR THE OBTAINING OF FORMILTRIMETILBICICLO (2.2.2) OCT-7-ENOS ISOMEROS.
IT1216894B (en) PHARMACEUTICAL COMPOSITION AND PROCEDURE FOR ITS PREPARATION.
IT8519115A0 (en) PIPARAZINE DERIVATIVE, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION.
IT8523529V0 (en) PERFECTED UNIT USABLE ONLY FOR MEDICAL APPLICATION.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 219076

Country of ref document: ES